Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance

[1] Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 Apr;61(2):69–90. JemalA BrayF CenterMM FerlayJ WardE FormanD Global cancer statistics CA Cancer J Clin 2011 Apr 61 2 69 90 10.3322/caac.2010721296855 Search in Google Scholar

[2] Siegel, RL, Miller, KD, Fuchs, H, Jemal, A. Cancer Statistics, 2021. CA Cancer J Clin. 2021: 71: 7–33. https://doi.org/10.3322/caac.21654. SiegelRL MillerKD FuchsH JemalA Cancer Statistics, 2021 CA Cancer J Clin 2021 71 7 33 https://doi.org/10.3322/caac.21654 10.3322/caac.2165433433946 Search in Google Scholar

[3] Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. (eds). SEER cancer statistics review, 1975–2014, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. HowladerN NooneAM KrapchoM MillerD BishopK KosaryCL (eds). SEER cancer statistics review, 1975–2014 National Cancer Institute Bethesda, MD https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Search in Google Scholar

[4] Bertuccio P, Rosato V, Andreano A, Ferraroni M, Decarli A, Edefonti V, et al. Dietary patterns and gastric cancer risk: a systematic review and meta-analysis. Ann Oncol Off J Eur Soc Med Oncol. 2013 Jun;24(6):1,450–8. BertuccioP RosatoV AndreanoA FerraroniM DecarliA EdefontiV Dietary patterns and gastric cancer risk: a systematic review and meta-analysis Ann Oncol Off J Eur Soc Med Oncol 2013 Jun 24 6 1,450 8 10.1093/annonc/mdt10823524862 Search in Google Scholar

[5] Ma J-L, Zhang L, Brown LM, Li J-Y, Shen L, Pan K-F, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012 Mar 21;104(6):488–92. MaJ-L ZhangL BrownLM LiJ-Y ShenL PanK-F Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality J Natl Cancer Inst 2012 Mar 21 104 6 488 92 10.1093/jnci/djs003330912922271764 Search in Google Scholar

[6] Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009 Jul 21;151(2):121–8. FuccioL ZagariRM EusebiLH LaterzaL CennamoV CeroniL Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009 Jul 21 151 2 121 8 10.7326/0003-4819-151-2-200907210-0000919620164 Search in Google Scholar

[7] Alix-Panabières C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 2012;63:199–215. Alix-PanabièresC SchwarzenbachH PantelK Circulating tumor cells and circulating tumor DNA Annu Rev Med 2012 63 199 215 10.1146/annurev-med-062310-09421922053740 Search in Google Scholar

[8] Kohler C, Barekati Z, Radpour R, Zhong XY. Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res. 2011 Aug;31(8):2,623–8. KohlerC BarekatiZ RadpourR ZhongXY Cell-free DNA in the circulation as a potential cancer biomarker Anticancer Res 2011 Aug 31 8 2,623 8 Search in Google Scholar

[9] Jin H, Ma Y, Shen Q, Wang X. Circulating methylated DNA as biomarkers for cancer detection. Methylation – DNA RNA Histones Dis Treat [Internet]. 2012 Nov 28 [cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection. JinH MaY ShenQ WangX Circulating methylated DNA as biomarkers for cancer detection Methylation – DNA RNA Histones Dis Treat [Internet] 2012 Nov 28 [cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection. 10.5772/51419 Search in Google Scholar

[10] Alix-Panabieres, C., Schwarzenbach, H., & Pantel, K.. Circulating tumor cells and circulating tumor DNA. Annu Rev Med, 2012;63,199–215. Alix-PanabieresC. SchwarzenbachH. PantelK. Circulating tumor cells and circulating tumor DNA Annu Rev Med 2012 63 199 215 10.1146/annurev-med-062310-094219 Search in Google Scholar

[11] Ghossein, RA, Bhattacharya, S, Rosai, J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res. 1999;5:1,950–1,960. GhosseinRA BhattacharyaS RosaiJ Molecular detection of micrometastases and circulating tumor cells in solid tumors Clin Cancer Res 1999 5 1,950 1,960 Search in Google Scholar

[12] Mocellin, S., Keilholz, U., Rossi, C. R., Nitti, D. Circulating tumor cells: the ‘leukemic phase’ of solid cancers. Trends Mol Med. 2006;12:130–139. MocellinS. KeilholzU. RossiC. R. NittiD Circulating tumor cells: the ‘leukemic phase’ of solid cancers Trends Mol Med 2006 12 130 139 10.1016/j.molmed.2006.01.00616488189 Search in Google Scholar

[13] Chimonidou, M., Strati, A., Tzitzira, A., Sotiropoulou, G., Malamos, N., Georgoulias, V., et al. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem. 2011;57:1,169–1,177. ChimonidouM. StratiA. TzitziraA. SotiropoulouG. MalamosN. GeorgouliasV. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells Clin Chem 2011 57 1,169 1,177 10.1373/clinchem.2011.16590221700955 Search in Google Scholar

[14] Kohler, C., Barekati, Z., Radpour, R., Zhong, X. Y. Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res. 2011;31:2,623–2,628. KohlerC. BarekatiZ. RadpourR. ZhongX. Y. Cell-free DNA in the circulation as a potential cancer biomarker Anticancer Res 2011 31 2,623 2,628 Search in Google Scholar

[15] Jin H, Ma Y, Shen Q, Wang X. Circulating methylated DNA as biomarkers for cancer detection. Methylation – DNA RNA Histones Dis Treat [Internet]. 2012 November 28 [cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection. JinH MaY ShenQ WangX Circulating methylated DNA as biomarkers for cancer detection Methylation – DNA RNA Histones Dis Treat [Internet] 2012 November 28 [cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection. 10.5772/51419 Search in Google Scholar

[16] Chen H-M, Fang J-Y. Epigenetic biomarkers for the early detection of gastrointestinal cancer. Gastrointest Tumors. 2014 May;1(4):201–8. ChenH-M FangJ-Y Epigenetic biomarkers for the early detection of gastrointestinal cancer Gastrointest Tumors 2014 May 1 4 201 8 10.1159/000380784466879626674521 Search in Google Scholar

[17] Karamitrousis EI, Balgkouranidou I, Xenidis N, Amarantidis K, Biziota E, Koukaki T, et al. Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients. Technol Cancer Res Treat. 2021 Jan–Dec;20:1533033820973279. doi: 10.1177/1533033820973279. PMID: 33928818; PMCID: PMC8113658. KaramitrousisEI BalgkouranidouI XenidisN AmarantidisK BiziotaE KoukakiT Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients Technol Cancer Res Treat 2021 Jan–Dec 20 1533033820973279. 10.1177/1533033820973279 PMID: 33928818; PMCID: PMC8113658. 811365833928818 Open DOISearch in Google Scholar

[18] Balgkouranidou I, Matthaios D, Karayiannakis A, Bolanaki H, Michailidis P, Xenidis N, et al. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Mutat Res. 2015 Aug;778:46–51. BalgkouranidouI MatthaiosD KarayiannakisA BolanakiH MichailidisP XenidisN Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients Mutat Res 2015 Aug 778 46 51 10.1016/j.mrfmmm.2015.05.00226073472 Search in Google Scholar

[19] Bu J, Lee TH, Jeong WJ, Poellmann MJ, Mudd K, Eun HS, et al. Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer. PLoS One. 2020 Dec 2;15(12):e0242145. doi: 10.1371/journal.pone.0242145. PMID: 33264292; PMCID: PMC7710035. BuJ LeeTH JeongWJ PoellmannMJ MuddK EunHS Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer PLoS One 2020 Dec 2 15 12 e0242145 10.1371/journal.pone.0242145 PMID: 33264292; PMCID: PMC7710035. 771003533264292 Open DOISearch in Google Scholar